The collective lawsuit has a very broad application, for two reasons: it both defends the natural right of all Mexicans – and not just those alive today but those yet to be born – and includes a declarative interpretation. That means it does not seek the payment of damages but rather a blanket, permanent ban on the outdoor cultivation of […]
Biotech stocks are known for their wild ways. Over the last few years, for instance, we have witnessed dozens of small-cap companies soar — as well as sink — following pivotal clinical or regulatory catalysts.Perhaps one of the most intriguing aspects of this phenomenon is that the biggest moves tend to occur in under-the-radar biotechs. Before skyrocketing by over 300% […]
Biotech Company Could Be on the Cusp of New Proenzyme Drug for the Treatment and Prevention of Certain Forms of Cancer
By iCELL News on March 12, 2015 · Sector
The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known Biotech stocks, would like to announce some recent breakthroughs in the development of new […]
In the end, Creative Edge Nutrition (FITX) was always more about lining Bill Chaaban’s pockets than becoming a major marijuana producer. Sure, a license to grow pot would have been a bonus, but isn’t it nice that Chaaban came out a winner anyway? And the real motive was evident to anybody with a grain of sanity. Unfortunately, those with pie-in-the-sky […]
Financial Stocks Up After Market: ACT, INTC, MYL, ICPT, GEVA, KITE, AXP, C, GS, MSAfter market today, banks traded higher. Fed has approved plans by various banks to raise dividends and buy back shares.After the market, C jumped +2.62%; MS popped nearly +3%. GS and AXP also traded up. AXP announced a $6.6 billion share buyback plan.After Tuesday’s steep selloff, […]
More money found it’s way out of the large cap indexes, moving into midcaps, biotechs and select leading names. Trading volume was light as the day was pretty slow. Leading stocks continue to outperform without flashing buy signals. Some of the outperformance is simply holding steady as the indexes sag. The biotech indexes, on the other hand, remain in strong […]
When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of a […]
View gallery.When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of […]
“Our life is March weather, savage and serene in one hour.” — Ralph Waldo Emerson
Substitute “biotechs” for “our life” and you have the investing version of Emerson’s quote. Depending on how binary events go, they can certainly become savage or serene quite quickly.We asked our team of experts for their top biotech picks to watch this month. Read below to […]
Annual health tech fests like the JPMorgan Health Care Conference, Biotech Showcase, and One Med Forum came and went this year in San Francisco. The star performers in this sector no doubt have a lot to brag about. They will also have a lot of explaining to do when the biotech and health care sectors eventually crash.The NASDAQ Biotechnology Index […]
